These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants. Siwawannapong K; Nemeth AM; Melander RJ; Rong J; Davis JR; Taniguchi M; Carpenter ME; Lindsey JS; Melander C ChemMedChem; 2022 Aug; 17(16):e202200286. PubMed ID: 35704751 [TBL] [Abstract][Full Text] [Related]
5. Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria. Dokla EME; Abutaleb NS; Milik SN; Li D; El-Baz K; Shalaby MW; Al-Karaki R; Nasr M; Klein CD; Abouzid KAM; Seleem MN Eur J Med Chem; 2020 Jan; 186():111850. PubMed ID: 31735572 [TBL] [Abstract][Full Text] [Related]
6. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs. Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444 [TBL] [Abstract][Full Text] [Related]
7. Second-Generation Meridianin Analogues Inhibit the Formation of Mycobacterium smegmatis Biofilms and Sensitize Polymyxin-Resistant Gram-Negative Bacteria to Colistin. Zeiler MJ; Melander RJ; Melander C ChemMedChem; 2020 Sep; 15(17):1672-1679. PubMed ID: 32662926 [TBL] [Abstract][Full Text] [Related]
8. Screening an Established Natural Product Library Identifies Secondary Metabolites That Potentiate Conventional Antibiotics. Mattingly AE; Cox KE; Smith R; Melander RJ; Ernst RK; Melander C ACS Infect Dis; 2020 Oct; 6(10):2629-2640. PubMed ID: 32810395 [TBL] [Abstract][Full Text] [Related]
9. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related]
10. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae. Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924 [TBL] [Abstract][Full Text] [Related]
11. New Class of Adjuvants Enables Lower Dosing of Colistin Against Acinetobacter baumannii. Minrovic BM; Jung D; Melander RJ; Melander C ACS Infect Dis; 2018 Sep; 4(9):1368-1376. PubMed ID: 29890069 [TBL] [Abstract][Full Text] [Related]
12. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli. Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988 [TBL] [Abstract][Full Text] [Related]
13. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. Personne Y; Curtis MA; Wareham DW; Waite RD J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721 [TBL] [Abstract][Full Text] [Related]
14. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria. Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey. Ece G; Samlioglu P; Atalay S; Kose S Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089 [TBL] [Abstract][Full Text] [Related]
17. Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model. Lin YW; Zhou QT; Han ML; Chen K; Onufrak NJ; Wang J; Turnidge JD; Howden BP; Forrest A; Chan HK; Li J Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229637 [TBL] [Abstract][Full Text] [Related]
18. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria. Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203 [TBL] [Abstract][Full Text] [Related]
19. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]